201 GSK Annual Report 2017 Strategic report Governance and remuneration Financial statements Investor information 33.
Share capital and share premium account Share Ordinary Shares of 25p each premium Number m m Share capital authorised At 31 December 2015 10,000,000,000 2,500 At 31 December 2016 10,000,000,000 2,500 At 31 December 2017 10,000,000,000 2,500 Share capital issued and fully paid At 1 January 2015 5,355,297,232 1,339 2,759 Issued under employee share schemes 6,010,415 1 72 At 31 December 2015 5,361,307,647 1,340 2,831 Issued under employee share schemes 7,008,415 2 87 Ordinary shares acquired by ESOP Trusts 36 At 31 December 2016 5,368,316,062 1,342 2,954 Issued under employee share schemes 4,237,758 1 55 Ordinary shares acquired by ESOP Trusts 10 At 31 December 2017 5,372,553,820 1,343 3,019 31 December 2017 31 December 2016 000 000 38,647 71,382 Number of shares issuable under employee share schemes 4,588,799 4,560,302 Number of unissued shares not under option At 31 December 2017, of the issued share capital, 66,696,677 shares were held in the ESOP Trusts, 414,605,950 shares were held as Treasury shares and 4,891,251,193 shares were in free issue.
All issued shares are fully paid.
The nominal, carrying and market values of the shares held in the ESOP Trusts are disclosed in Note 43, Employee share schemes.
